Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
about
Do stroke models model stroke?Launching invasive, first-in-human trials against Parkinson's disease: ethical considerationsGinsenoside rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic windowNeuroprotection for ischemic stroke: past, present and futurePostischemic PKC activation rescues retrograde and anterograde long-term memoryIn vivo imaging of brain ischemia using an oxygen-dependent degradative fusion protein probeNitrones as therapeutics.Neuroprotection in cerebral infarction: the opportunity of new studies.Detrimental effects of tropisetron on permanent ischemic stroke in the rat.Clinical trials for neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside.Laser therapy in acute stroke treatment.Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke.A large-scale chemical screen for regulators of the arginase 1 promoter identifies the soy isoflavone daidzeinas a clinically approved small molecule that can promote neuronal protection or regeneration via a cAMP-independent pathway.Role of Nogo-A in neuronal survival in the reperfused ischemic brainDelayed histochemical alterations within the neurovascular unit due to transient focal cerebral ischemia and experimental treatment with neurotrophic factors.Protective efficacy of a single salvianolic acid A treatment on photothrombosis-induced sustained spatial memory impairmentsRodent models of focal cerebral ischemia: procedural pitfalls and translational problemsEpigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.Translational pharmacokinetics: challenges of an emerging approach to drug development in stroke.Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trialSimultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials.Acid-sensing ion channels in acidosis-induced injury of human brain neuronsSmall molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injuryStem cell therapy for cerebral ischemia: from basic science to clinical applications.Intravenous administration of achyranthes bidentata polypeptides supports recovery from experimental ischemic stroke in vivo.D-cycloserine 24 and 48 hours after asphyxial cardiac arrest has no effect on hippocampal CA1 neuropathologyAre Underlying Assumptions of Current Animal Models of Human Stroke Correct: from STAIRs to High Hurdles?An in vitro study of neuroprotective properties of traditional Chinese herbal medicines thought to promote healthy ageing and longevity.A novel effect of Noscapine on patients with massive ischemic stroke: A pseudo-randomized clinical trialAdrenomedullin promotes differentiation of oligodendrocyte precursor cells into myelin-basic-protein expressing oligodendrocytes under pathological conditions in vitro.Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental strokeTransient focal cerebral ischemia induces long-term cerebral vasculature dysfunction in a rodent experimental stroke modelEffects of the combined treatment of bone marrow stromal cells with mild exercise and thyroid hormone on brain damage and apoptosis in a mouse focal cerebral ischemia model.Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery.Clinical pharmacological issues in the development of acute stroke therapies.Arctic ground squirrel neuronal progenitor cells resist oxygen and glucose deprivation-induced deathPathways to ischemic neuronal cell death: are sex differences relevant?Neuroprotection and stroke: time for a compromise.Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.A systematic review and meta-analysis of buyang huanwu decoction in animal model of focal cerebral ischemia
P2860
Q24288828-66048183-3B74-44CB-AE7D-62A83320C466Q24289526-160DCFE6-D2FE-4C20-8A37-91608FB94EEAQ24615554-EFC4AB27-2532-430C-AF7D-97D977858117Q24645185-7A1B8BA1-8B82-4940-8CD5-08BAFDFECD21Q24646400-D46D43FD-65DF-4583-9904-BEA884A0B624Q28484495-5BFBDE6C-57FC-4565-B669-0585152AFA03Q30484564-8FCB78EA-2BA1-41D2-A09C-5FE761C3A135Q31134847-EF5341AC-87BA-40C3-A75F-2C733BB0AC88Q33318585-9EC83A11-9D49-413C-9E35-A8B84B651045Q33357329-993356BE-3F95-4BEF-8568-BBC60EE0AE46Q33360428-8BFE636E-2D89-4C51-95BE-82D855865F28Q33482531-F879DCDD-1225-42AF-9F83-90329B710ED7Q33523661-3E38CD13-D5C8-4A5F-89FE-EC4D3876D43FQ33525257-D600E7B3-8BDC-4103-87CC-4448FFA26202Q33605893-154AC28C-0AB4-4D5B-806F-771356E3EF67Q33631320-7C0A0B2F-BD5D-4755-BC46-8FD24C90D11EQ33647103-045A704E-3EF8-466A-8B76-C3365B55F0BBQ33693885-1DA8C1E1-B839-486A-8F92-A1660A9B18A9Q33882182-D7B91791-BA11-4322-BB7F-E7FEE0B52EC7Q34009248-A429AE83-7F37-4569-8416-80AE1818CCECQ34037915-23681318-5DDB-4D35-93CC-619F09F5A1ACQ34044578-29BDA44D-D5DF-4CC6-8FA6-CE55FBE5C6B1Q34066937-C3982A77-6052-45BB-8A23-2C775719E689Q34129832-052CDD7D-9023-4ECB-93F9-046819CE7AC9Q34611715-4AF6F1CB-2D7F-40CE-85C4-2D627746F451Q34727215-1128D81B-B5F7-4B8B-BCE4-6E954589B11EQ34901610-4E6279A8-7258-4053-96DB-A6A638CDE67AQ35076788-D758CF76-AB7F-40CC-92BA-00C524EC10CDQ35399427-64ED26F7-D2A6-4913-8363-D5ACCB062A10Q35893763-BEC32C03-073C-4433-8164-7EF80103AC50Q36104426-0EF3DA82-75D7-44C0-99EE-0D196272036AQ36163382-75DF7AA0-1D40-4F28-AE2D-8FF4B9D0D7EFQ36382301-0DA72378-16FA-4138-A7F6-60BB29815185Q36496980-8CA6CE59-E925-48BA-88DB-75553BD2E307Q36496990-CB8ADE39-9C13-4232-B2CE-7CA825AB02A0Q36621226-D5E5EB3F-4120-4FF3-841D-EA2CDD9D54F9Q36761504-F8296AAF-5611-4E15-8465-05F391AF0C09Q36922560-299ECD60-058E-43FD-9760-EB0EC40C8FAFQ36925788-DCA7143A-166B-454D-BA8F-AABFF69776B6Q36943081-E02A585F-7666-40B9-9F29-19C85C40A095
P2860
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@ast
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@en
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@nl
type
label
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@ast
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@en
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@nl
prefLabel
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@ast
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@en
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@nl
P2860
P356
P1433
P1476
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
@en
P2093
Marc Fisher
Sean I Savitz
P2860
P304
P356
10.1002/ANA.21127
P577
2007-05-01T00:00:00Z